UFP Technologies, Inc.
$201.08
▼
-1.02%
2026-04-21 10:00:01
www.ufpt.com
NCM: UFPT
Explore UFP Technologies, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.54 B
Current Price
$201.08
52W High / Low
$274.93 / $182.87
Stock P/E
22.53
Book Value
$54.95
Dividend Yield
—
ROCE
16.02%
ROE
17.82%
Face Value
—
EPS
$8.75
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
4,846
Beta
1.17
Debt / Equity
36.45
Current Ratio
2.69
Quick Ratio
1.52
Forward P/E
17.57
Price / Sales
2.58
Enterprise Value
$1.69 B
EV / EBITDA
15.03
EV / Revenue
2.8
Rating
Buy
Target Price
$324.5
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Net margin remains healthy.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Beta Bionics, Inc. | $12.91 | — | $576.08 M | — | -24.07% | -40.26% | $32.71 / $8.8 | $6.48 |
| 2. | Spectral AI, Inc. | $1.89 | — | $60.15 M | — | -1104.36% | 116.67% | $3.21 / $1.13 | $-0.19 |
| 3. | Electromed, Inc. | $25.4 | 23.98 | $215.65 M | — | 22.29% | 20.2% | $30.73 / $17.73 | $5.49 |
| 4. | Bluejay Diagnostics, Inc. | $1.97 | — | $1.94 M | — | -115.88% | -1.17% | $16.68 / $1.65 | $9.88 |
| 5. | Nexalin Technology, Inc. | $0.47 | — | $9.54 M | — | -223.88% | -2.22% | $2 / $0.33 | $0.2 |
| 6. | Boston Scientific Corporation | $65.03 | 33.52 | $96.13 B | 0% | 10.39% | 12.45% | $109.5 / $60.59 | $16.34 |
| 7. | Neogen Corporation | $9.63 | — | $2.08 B | — | -0.05% | -25.57% | $11.43 / $4.32 | $9.68 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 148.91 M | 154.56 M | 151.18 M | 148.15 M | 144.07 M | — |
| Operating Profit | 21 M | 23.68 M | 24.86 M | 23.43 M | 23.44 M | — |
| Net Profit | 17.57 M | 16.38 M | 17.18 M | 17.18 M | 16.38 M | — |
| EPS in Rs | 2.28 | 2.12 | 2.23 | 2.23 | 2.12 | 2.11 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 602.8 M | 504.42 M | 400.07 M | 353.79 M |
| Operating Profit | 92.97 M | 84.47 M | 61.34 M | 44.46 M |
| Net Profit | 68.31 M | 58.98 M | 44.92 M | 41.79 M |
| EPS in Rs | 8.86 | 7.65 | 5.82 | 5.42 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 655.08 M | 629 M | 404.14 M | 378.19 M |
| Total Liabilities | 231.2 M | 286.24 M | 118.05 M | 140.65 M |
| Equity | 423.88 M | 342.76 M | 286.09 M | 237.54 M |
| Current Assets | 201 M | 194.94 M | 144.63 M | 116.35 M |
| Current Liabilities | 74.86 M | 76.3 M | 58.21 M | 55.96 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 91.91 M | 66.59 M | 41.33 M | 17.74 M |
| Investing CF | -27.6 M | -210.16 M | -10.49 M | 1.29 M |
| Financing CF | -58.16 M | 152.39 M | -30.02 M | -25.89 M |
| Free CF | 78.98 M | 56.94 M | 30.84 M | 3.96 M |
| Capex | -12.93 M | -9.66 M | -10.49 M | -13.78 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 26.08% | 13.08% | — | — |
| Earnings Growth % | 31.29% | 7.5% | — | — |
| Profit Margin % | 11.69% | 11.23% | 11.81% | — |
| Operating Margin % | 16.75% | 15.33% | 12.57% | — |
| Gross Margin % | 29.08% | 28.05% | 25.51% | — |
| EBITDA Margin % | 18.99% | 17.24% | 19.04% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.